source
- Nobel laureate Jennifer Doudna unveils AI-driven platform to design novel gene‑editing enzymesJennifer Doudna, the Nobel laureate who co‑invented CRISPR, announced a new AI‑powered platform for creating gene‑editing proteins in a paper published today in Science. The system uses computation…
- Lonza urges biotech firms to prioritize early de-risking to streamline IND pathIn a recent interview, Jaime Okray of Lonza highlighted that emerging biotech companies are shifting focus from pure speed to early identification of development risks as they aim for an IND filing…